Thu, November 7, 2019
Wed, November 6, 2019
Tue, November 5, 2019
Mon, November 4, 2019
Fri, November 1, 2019
Thu, October 31, 2019
Wed, October 30, 2019
Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019

Whitney Ijem Initiated (SRPT) at Strong Buy and Held Target at $183 on, Nov 1st, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-183-on-nov-1st-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Whitney Ijem of Guggenheim, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $183 on, Nov 1st, 2019.

Whitney has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Whitney's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Whitney


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $180 on, Friday, September 27th, 2019
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $181 on, Tuesday, August 20th, 2019
  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $201 on, Tuesday, August 20th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, August 20th, 2019
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $220 on, Monday, July 1st, 2019